Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : PMS-101
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase I/ Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study to Evaluate the Safety, Tolerability and Efficacy in Patients With Burn(s)
Details : PMS-101 is a drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Burns.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
June 03, 2024
Lead Product(s) : PMS-101
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase I/ Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
